文献速递消化道肿瘤与早癌消化内镜

内镜筛查对上消化道癌死亡率的影响:一项基于社区的多中心整群随机临床试验

Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical Trial.
PubMed 文献 · Gastroenterology · 2024-12-18

该研究在中国高危和非高危地区开展社区多中心整群随机试验,纳入234635名参与者,筛查组受邀接受内镜筛查,对照组接受常规照护。高危地区筛查组7.5年内上消化道癌调整累积死亡风险0.77% vs 对照组0.99%(风险比0.78,95%CI 0.66-0.91);非高危地区为0.26% vs 0.30%(风险比0.86,95%CI 0.65-1.13)。结论为高危地区受邀内镜筛查降低上消化道癌死亡率,非高危地区基于风险评分的筛查未显著降低死亡率,但需更长随访。

要点

  • 高危地区受邀内镜筛查降低上消化道癌死亡风险(风险比0.78,95%CI 0.66-0.91)。
  • 非高危地区基于风险评分受邀筛查未显著降低死亡率(风险比0.86,95%CI 0.65-1.13)。
  • 非高危地区结论需更长随访时间验证,原文指出需要更长随访。

核心结论

  • 高危地区受邀内镜筛查可降低上消化道癌死亡率(风险比0.78,95%CI 0.66-0.91)。
  • 非高危地区基于风险评分的受邀内镜筛查未显著降低上消化道癌死亡(风险比0.86,95%CI 0.65-1.13),但需更长随访时间。

研究设计与样本

  • 社区多中心整群随机临床试验,在中国高危和非高危地区开展,随机化和招募于2015年至2017年进行,随访至2022年。
  • 干预为受邀接受内镜筛查,对照为常规照护(未筛查);非高危地区筛查组中仅风险评分评估为高风险的参与者受邀接受内镜筛查。
  • 意向筛查分析共纳入234635名参与者,中位年龄52岁。
  • 高危地区:筛查组64836人(81个整群),对照组59379人(82个整群)。
  • 非高危地区:筛查组58367人(92个整群),对照组52053人(90个整群)。

主要发现

  • 高危地区7.5年内上消化道癌死亡:筛查组480例(调整累积风险0.77%)vs 对照组545例(0.99%),风险比0.78(95%CI 0.66-0.91)。
  • 非高危地区调整风险:筛查组0.26%(146例死亡)vs 对照组0.30%(149例死亡),风险比0.86(95%CI 0.65-1.13)。
  • 主要结局为经基线特征和整群效应调整后的上消化道癌累积死亡风险。

局限性

  • 非高危地区基于风险评分的受邀内镜筛查未显著降低上消化道癌死亡,原文结论指出需要更长随访时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Population-based observational studies suggest that endoscopic screening may reduce upper gastrointestinal cancer mortality. We aimed to quantify the effect of endoscopy screening. METHODS: This is a community-based, multicenter, cluster randomized clinical trial conducted in both high-risk and non-high-risk areas of China. Randomization and recruitment occurred between 2015 and 2017, with follow-up conducted until 2022. The intervention was an invitation to receive endoscopic screening, as opposed to receiving usual care (unscreened). In non-high-risk areas, only participants assessed as high-risk by risk scores in the screening group were invited for endoscopic screening. The primary outcome was the cumulative risk of death from upper gastrointestinal cancer, adjusted for baseline characteristics and cluster effects. RESULTS: A total of 234,635 participants were included in the intention-to-screen analysis, with a median age of 52 years. In high-risk areas, 64,836 individuals from 81 clusters were randomized to the screening group, and 59,379 individuals from 82 clusters were randomized to the control group. In non-high-risk areas, 58,367 individuals from 92 clusters were randomized to the screening group, 52,053 individuals from 90 clusters were randomized to the control group. Among high-risk areas, 480 (adjusted cumulative risk, 0.77%) died due to upper gastrointestinal cancers within 7.5 years in the screening group vs 545 (0.99%) deaths in the control group (risk ratio, 0.78; 95% confidence interval, 0.66-0.91). Among non-high-risk areas, adjusted risk was 0.26% (146 deaths) in the screening group and 0.30% (149 deaths) in the control group (risk ratio, 0.86; 95% confidence interval, 0.65-1.13). CONCLUSIONS: An invitation to endoscopic screening reduced upper gastrointestinal cancer mortality in high-risk areas. In non-high-risk areas, an invitation to endoscopic screening based on risk scores did not significantly decrease upper gastrointestinal cancer deaths, but longer follow-up time was required. (Chinese Clinical Trial Registry Identifier: ChiCTR-EOR-16008577.).

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Xia C, Li H, Xu Y, et al. Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical Trial. Gastroenterology. 2024. PMID: 39706350. doi:10.1053/j.gastro.2024.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。